Katzung Pharmaceuticals Private Limited

Pharmaceutical company specializing in various medical formulations for multiple health conditions.

2017 | Medak, Telangana (India) | Active
Last Updated: January 27, 2025

Katzung Pharmaceuticals Profile

Key Indicators

  • Authorised Capital ₹ 0.50 M
  • Paid Up Capital ₹ 0.50 M
  • Company Age 7 Year, 8 Months
  • Last Filing with ROC 31 Mar 2023
  • Revenue Growth 4.62%
  • Profit Growth -0.92%
  • Ebitda -4.75%
  • Net Worth 36.69%
  • Total Assets 14.55%

About Katzung Pharmaceuticals

Katzung Pharmaceuticals Private Limited (KPPL) is a Private Limited Indian Non-Government Company incorporated in India on 27 June 2017 (Seven years and eight months 1 days old ). Its registered office is in Medak, Telangana, India.

The Company is engaged in the Pharma Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.

Syam Madivada, Amar Vennapusa, Mahesh Jambuladinne, and One other member serve as directors at the Company.

Company Details

Corporate Identity Details

  • CIN/LLPIN

    U74999TG2017PTC117959

  • Company No.

    117959

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    27 Jun 2017

  • Date of AGM

    30 Sep 2023

  • Date of Balance Sheet

    31 Mar 2023

  • Listing Status

    Unlisted

  • ROC Code

    Roc Hyderabad

Industry

Pharma

Who are the key members and board of directors at Katzung Pharmaceuticals?

Financial Performance of Katzung Pharmaceuticals.

Katzung Pharmaceuticals Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 4.62% increase. The company also saw a slight decrease in profitability, with a 0.92% decrease in profit. The company's net worth Soared by an impressive increase of 36.69%.

Graph illustrating revenue growth over time
Graph showing profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
4.62%
Revenue from Operations
4.62%
Total Assets
14.55%
Profit or Loss
-0.92%
Net Worth
36.69%
EBITDA
-4.75%

What is the Ownership and Shareholding Structure of Katzung Pharmaceuticals?

Unlock access to Katzung Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Indicator graph

Charges (Loans)

Placeholder for charges-related data

There are no open charges registered against the company as per our records.

How Many Employees Work at Katzung Pharmaceuticals?

Katzung Pharmaceuticals has a workforce of 30 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Graph showing employee growth trends

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Katzung Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Katzung Pharmaceuticals's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Katzung Pharmaceuticals

Recent activity within the organization

  • Annual General Meeting

    Katzung Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.

    30 Sep 2023

  • Balance Sheet

    Katzung Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Hyderabad.

    31 Mar 2023

  • Director Appointment

    Kranthi Kumar Chintala was appointed as a Additional Director was appointed as a Additional Director on 08 Jul 2017 & has been associated with this company since 7 years 7 months .

    08 Jul 2017

  • Director Appointment

    Syam Sundar Mukharjee Madivada was appointed as a Director was appointed as a Director on 27 Jun 2017 & has been associated with this company since 7 years 8 months .

    27 Jun 2017

  • Director Appointment

    Amar Vennapusa was appointed as a Director was appointed as a Director on 27 Jun 2017 & has been associated with this company since 7 years 8 months .

    27 Jun 2017

  • Director Appointment

    Mahesh Babu Jambuladinne was appointed as a Director was appointed as a Director on 27 Jun 2017 & has been associated with this company since 7 years 8 months .

    27 Jun 2017

Frequently asked questions

  • What is the Incorporation or founding date of Katzung Pharmaceuticals Private Limited?

    Katzung Pharmaceuticals Private Limited was incorporated on 27 Jun 2017.

  • What is authorized share capital and paid-up capital of Katzung Pharmaceuticals Private Limited?

    The authorized share capital of Katzung Pharmaceuticals Private Limited is ₹ 0.50 M and paid-up capital is ₹ 0.50 M.

  • Who are the current board members & directors of Katzung Pharmaceuticals Private Limited?

    Currently 4 directors are associated with Katzung Pharmaceuticals Private Limited.

    • Syam Sundar Mukharjee Madivada
    • Amar Vennapusa
    • Mahesh Babu Jambuladinne
    • Kranthi Kumar Chintala
  • What is the registered address of Katzung Pharmaceuticals Private Limited?

    As per Ministry of Corporate Affairs (Mca), the registered address of Katzung Pharmaceuticals Private Limited is Plot No 368 Raghavendra Colony Beeramguda, Patancheruvu India, Hyderabad, Telangana, 502032.

  • What is the corporate identification number (CIN) and company number of Katzung Pharmaceuticals Private Limited?

    The corporate identification number (CIN) of Katzung Pharmaceuticals Private Limited is U74999TG2017PTC117959 and the company number is 117959 as per Ministry of Corporate Affairs (MCA).

  • What is the official website of Katzung Pharmaceuticals Private Limited?

    The Official website of Katzung Pharmaceuticals Private Limited is https://www.katzungpharma.com

  • What has been the recent revenue trend for Katzung Pharmaceuticals Private Limited?

    According to the financial reports for the fiscal year 2023, the revenue trend for Katzung Pharmaceuticals Private Limited has risen by 4.62%.

  • How many employees does Katzung Pharmaceuticals Private Limited currently have?

    As Per 2023 financial reports, 30 employees are currently employed by Katzung Pharmaceuticals Private Limited.

  • What change has been observed in the net worth of Katzung Pharmaceuticals Private Limited, and by what percentage?

    The financial reports for the fiscal year 2023 indicates that The net worth of Katzung Pharmaceuticals Private Limited has experienced an upsurge of 36.69%.

  • When was the last Balance Sheet of Katzung Pharmaceuticals Private Limited filed with the ROC?

    The most recent Balance Sheet for Katzung Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2023.

People also Viewed

Similar Companies Based on Drug Formulation & Development